Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Ultragenyx Pharmaceutical Inc. (RARE)

Johnson Fistel, PLLP said it is investigating potential fiduciary-duty claims on behalf of long-term Ultragenyx shareholders against certain officers and directors. The announcement signals legal/governance risk for RARE, though no financial figures or case outcomes were disclosed.

Analysis

Johnson Fistel, PLLP said it is investigating potential fiduciary-duty claims on behalf of long-term Ultragenyx shareholders against certain officers and directors. The announcement signals legal/governance risk for RARE, though no financial figures or case outcomes were disclosed.